Cetuximab resistance can also be mediated by the activation of the Akt signalling pathway in an alternative way, such as the overexpression of other growth factors (TGFβ, VEGF, and NGF) and their associated receptors by the tumour cells and/or the tumour microenvironment [179]. Here, AKT1 is linked to neoplasm.